Dallah Healthcare Company

$ 115.90 -0.94 %

Operating within the Kingdom of Saudi Arabia, Dallah Healthcare Company specializes in delivering and managing a comprehensive array of healthcare services and infrastructure. Its core activities encompass the operation, management, outfitting, and growth of hospitals, various medical establishments, polyclinics, residential healthcare complexes, and associated land. Additionally, it supplies essential personnel and ancillary services to both hospitals and medical centers. Beyond direct healthcare provision, Dallah Healthcare is also involved in the production and supply of pharmaceutical, herbal, and cosmetic goods, distributing them to individual pharmacies, health and beauty retailers, hospitals, and government bodies. The firm further extends its expertise to include the oversight and running of hospitals belonging to external entities, alongside offering various supplementary support functions. This encompasses the administration of private hospitals, specialized medical and diagnostic centers, and an analytical laboratory, coupled with the direct provision of medical care. Originally established as Dallah Healthcare Holding Company, the organization officially adopted its current name, Dallah Healthcare Company, in November 2016. Founded in 1994, its corporate headquarters are situated in Riyadh, Saudi Arabia, and it operates as a subsidiary of Dallah Al-Barakah Holding.

CEO: Ahmad bin Saleh Babaeer - https://www.dallahhealth.com

Price objectif

-

Recommandation

-

DCF

$ 312.81

Loading data...

4004.SR vs S&P500

Loading data...

No data available.

Quick ratio

0.98

indicates that the company may have difficulty covering its short-term debts with its readily available assets.

P/E ratio

25.36

is considered reasonable, suggesting that the company has a valuation in line with its current profits.

EPS

4.57

is the net profit of a company divided by the number of outstanding shares, indicating the profit earned per share.

ROE

11.31 %

reflects reasonable profitability, showing good use of equity.

ROIC

5.65 %

generates a return higher than the cost of its capital, thereby creating value for its investors.

WACC

4.84

is a company's average cost of capital, weighted by the proportion of debt and equity in its financing. It represents the minimum return the company must generate to satisfy its investors.

Debt-to-Equity Ratio

0.98

indicates that the company uses more equity than debt, suggesting prudent management.

Free cash flow per share

-2.09

is a measure of a company's financial flexibility that is determined by dividing free cash flow by the total number of shares outstanding.

Dividend payout ratio

43.27 %

indicates that the company is retaining a large portion of its profits to reinvest in growth

Earnings per share

Loading data...

No data available.

Financials

Piotroski score
5 indicates moderate financial health
Altman score
2.31 indicates an uncertain financial situation
Loading data...

No data available.

Cash / Debt

Cash Ratio
0.11 indicates liquidity risk, as the company may not have enough cash to meet its immediate obligations
Debt Ratio
0.43 indicates that the company uses little debt to finance its assets, suggesting good financial stability
Loading data...

No data available.

Free Cash Flow

Loading data...

No data available.

Earnings Per Share (annual)

Loading data...

No data available.

Sales

Loading data...

No data available.